Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · USD

$3.06

+0.06 (+2.2%)· Recorded snapshot

Market cap	106.2M
Net income (ttm)	-10.4M
EPS (ttm)	-$0.31
Shares out	34.8M
Volume	149,826.842
Beta	0.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -10.4M
EPS (ttm): -$0.31
Market cap: 106.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-73.2

P25 n/aP50 n/aP75 n/a

ROIC-47.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ANIX indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000715446
Company name	Anixa Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	03528H109
Earnings date	2026-09-09
Earnings time	amc
Employees	4
Employees change	-1
Employees growth	-20%
Enterprise value	$92.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-09
Fiscal year end	October
Founded	1982
Industry	Biotechnology
IPO date	1987-01-01
Is primary listing	Yes
Is SPAC	No
ISIN number	US03528H1095
Last 10-K release date	2026-01-12
Last earnings date	2026-09-09
Last refreshed	2026-11-04
Last stock split date	2015-06-26
Last stock split type	Reverse
Market cap	$106.2M
Market cap category	Micro-Cap
Next earnings date	2027-01-11
Options	Yes
Price	$3.06
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	ANIX
U.S. state	California
Website	https://www.anixa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-10.15%
FCF / EV yield	-7.97%
FCF yield	-6.95%
P/B ratio	7.3x
Price / tangible book value	7.34x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-2.6M
ROA	-41.93%
ROA (5Y)	-32.41%
ROCE	-82.35%
ROE	-73.17%
ROE (5Y)	-54.11%
ROIC	-47.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$39,000
EBIT	$-11M
EPS	$-0.31
FCF per share	$-0.21
Financing cash flow	$5.2M
Free cash flow	$-7.4M
Free cash flow minus SBC	$-10.4M
Investing cash flow	$2.1M
Net cash flow	$-97,000
Net income	$-10.4M
Operating cash flow minus SBC	$-10.4M
Operating income	$-11M
Stock-based compensation	$3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.42
Debt / equity	0.01
Long-term assets	$163,000
Long-term liabilities	$128,000
Net cash (debt)	$13.7M
Net cash / market cap	12.89%
Net cash growth	-13.44%
Net debt / equity	-1.04
Piotroski F-Score	2
Property, plant and equipment	$163,000
Shareholders' equity	$13.2M
Tangible book value	$14.5M
Tangible book value per share	$0.42
Total assets	$15.1M
Total cash	$13.9M
Total debt	$174,000
Total liabilities	$1.9M
WACC	6.86%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$14.9M
Current liabilities	$1.7M
Current ratio	8.54
Net working capital	$-652,000
Quick ratio	7.94
Working capital	$13.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.79%
Dividend yield	0%
Shareholder yield	-3.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-49.92%
10Y return CAGR	-6.68%
10Y total return	-49.92%
150-day SMA	$2.99
15Y price change	-27.69%
15Y return CAGR	-2.14%
15Y total return	-27.69%
1D price change	2.17%
1M price change	3.56%
1M total return	3.56%
1W price change	-6.86%
1W total return	-6.86%
1Y price change	-26.03%
1Y return CAGR	-26.04%
1Y total return	-26.03%
20-day SMA	$2.91
200-day SMA	$2.97
20Y price change	-77.37%
20Y return CAGR	-7.16%
20Y total return	-77.37%
3M price change	-10.67%
3M total return	-10.67%
3Y price change	-4.53%
3Y return CAGR	-1.53%
3Y total return	-4.53%
50-day SMA	$2.95
50-day SMA vs 200-day SMA	50under200
52-week high	$5.46
52-week high date	2025-12-09
52-week low	$2.32
52-week low date	2026-06-11
5Y price change	-41.25%
5Y return CAGR	-10.09%
5Y total return	-41.25%
6M price change	-2.71%
6M total return	-2.71%
After-hours change	-0.49%
After-hours close	$3.06
After-hours price	$3.04
All-time high	$259.38
All-time high date	1993-07-07
All-time low	$0.60
All-time low date	2017-08-15
Average true range (ATR)	$0.18
Average volume	193.3K
Beta (1Y)	1
Beta (2Y)	0.71
Beta (5Y)	0.48
Change from 52-week high	-44.02%
Change from 52-week low	31.68%
Change from all-time high	-98.82%
Change from all-time low	409.08%
Change from open	0.49%
Day's gap	1.67%
Dollar volume	$457,721
High price	$3.19
Low price	$3.01
Monthly RSI	48.86
Open price	$3.04
Position in 52-week range	25%
Premarket change	1.15%
Premarket close	$3.06
Premarket price	$3.09
Premarket volume	5.1K
Previous close	$2.99
Price vs 150-day SMA	2.24%
Price vs 20-day SMA	4.98%
Price vs 200-day SMA	3.04%
Price vs 50-day SMA	3.66%
Relative volume	0.78
RSI	53.51
Sharpe ratio	-0.19
Sharpe ratio (3Y)	0.29
Sharpe ratio (5Y)	0.19
Sortino ratio	-0.18
Sortino ratio (3Y)	0.57
Sortino ratio (5Y)	0.38
Volume	149.8K
Weekly RSI	50.36
YTD price change	-2.08%
YTD total return	-2.08%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32.8M
Float percentage	94.32%
Shares change (QoQ)	1.75%
Shares change (YoY)	3.79%
Shares held by insiders	5.68%
Shares held by institutions	15.61%
Shares outstanding	34.8M
Short % of float	5.07%
Short % of shares	4.78%
Short ratio	5.2 days

Deeper analysis on ANIX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ANIX report

Is a complete ANIX research report available?

No complete published report is available for Anixa Biosciences, Inc. (ANIX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Anixa Biosciences, Inc. (ANIX)

Price

Financial snapshot

Fair-value bridge

Latest news · ANIX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ANIX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ANIX

Frequently asked questions